Day One Biopharmaceuticals
DAWN
DAWN
174 hedge funds and large institutions have $560M invested in Day One Biopharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 71 increasing their positions, 56 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
174
Holders Change
-10
Holders Change %
-5.43%
% of All Funds
2.33%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
26
Increased
71
Reduced
56
Closed
34
Calls
$902K
Puts
$581K
Net Calls
+$321K
Net Calls Change
+$855K
Top Buyers
| 1 |
BlackRock
New York
|
$63.9M |
| 2 |
DM
Deerfield Management
New York
|
$24.2M |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$6.14M |
| 4 |
Renaissance Technologies
New York
|
$6.5M |
| 5 |
Morgan Stanley
New York
|
$8.8M |
